Enanta Pharmaceuticals
ENTA
#7731
Rank
NZ$0.74 B
Marketcap
NZ$25.67
Share price
3.64%
Change (1 day)
106.83%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2025 (TTM): -NZ$0.14 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are NZ$65.32 Million. In 2024 the company made an earning of -NZ$0.18 Billion, an increase over its 2023 earnings that were of -NZ$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.14 Billion-23.45%
2024 -NZ$0.18 Billion-23.87%
2023 -NZ$0.23 Billion4.39%
2022 -NZ$0.22 Billion-4.4%
2021 -NZ$0.23 Billion91.12%
2020 -NZ$0.12 Billion-407.13%
2019 NZ$38.47 M-78.63%
2018 NZ$0.18 B117.97%
2017 NZ$82.61 M-574.65%
2016 -NZ$17.41 Million-110.83%
2015 NZ$0.16 B-4.5%
2014 NZ$0.16 B-638.53%
2013 -NZ$31.26 Million-137.98%
2012 NZ$82.28 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$45.95 B-34,342.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$27.91 B-20,904.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
NZ$11.66 B-8,795.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$8.95 B-6,771.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$23.26 B-17,435.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.97 B-12,749.60%๐Ÿ‡บ๐Ÿ‡ธ USA